Page 269 - ASHG 2013 Program Guide

256  
POSTER SESSIONS
W=W
ednesday authors will present; T=Thursday authors will present; F=Friday authors will pr
esent
3496
T Angiogenesis in chronic hepatic patients.
I. A. Helwa, H. A. El Dakhakhny, N. M. Kholoussi,
R. F. Mahmoud, A. Hamada.
3497
F Cancer phenotypes of germline monoallelic
ATM
mutation carriers and their families.
H. LaDuca,
A. Stuenkel, S. Keiles, T. Pesaran, S. Tandy, E. Chen,
V. Speare, C. Radford, C. Gau.
3498
W Contralateral mastectomy and survival after
breast cancer in
BRCA1
and
BRCA2
mutation carriers.
K. Metcalfe, S. Gershman, P. Ghadirian, H. Lynch,
C. Snyder, N. Tung, C. Kim-Sing, A. Eisen, W. Foulkes,
B. Rosen, P. Sun, S. Narod.
3499
T Genetic diagnosis of a series of Brazilian
patients with pheochromocytomas and
paragangliomas.
O. Moraes, D. Oliveira, B. Araújo,
C. Meireles, L. Vianna, J. Mazzeu, M. Batista, A. Lofrano-
Porto.
3500
F Prevalence of succinate dehydrogenase-
deficient GIST in adults with GIS .
I. R. Rainville, E. J.
Root, A. J. Wagner, S. George, C. L. Corless, J. E. Garber,
J. A. Hornick.
3501
W Value of microRNA-based molecular profiling
in cancer of unknown primary cases for familial
cancer risk assessment and genetic counseling.
E. R.
Wassman, E. Goren, J. Hale, C. Hogan, B. St.Cyr, M. O.
Sanden.
3502
T Identification of tissue-specific long intergeni
non-coding RNAs in normal prostate tissue.
Y. Zhang,
A. J. French, A. A. Nair, S. McDonnell, S. Middha, S. Riska,
Z. Fogarty, D. Schaid, S. N. Thibodeau.
3503
F The novel founder
MSH6
mutation c.10C
.
T is
an important cause of Lynch syndrome in the French
Canadian population.
E. Castellsague, J. Liu, A. Volenik,
R. Gagne, B. Maranda, S. Giroux, J. Latreille, L. Palma,
L. Kasprzak, V. Marcus, M. Breguet, S. Nolet, A. M.
Mes-Masson, D. Provencher, G. Chong, F. Rousseau,
W. Foulkes.
3504
W Whole exome sequencing of familial
aggregations of radiation-associated meningiomas.
A. Pathak, R. Bruchim, D. R. Stewart, S. Sadetzki.
3505
T Global differential expressions of isoforms of
miRNA in retinoblastoma: Correlation with level of
expressed 3
9
-5
9
-
exonucleases.
A. Ganguly, J. Leipzig,
J. Richards-Yutz, J. Purrazzella.
3506
F
MALAT1
is deregulated and co-expressed with
CREBBP
in the long non-coding transcriptome of
childhood acute lymphoblastics leukemia.
R. Vidal,
C. Richer, JF. Spinella, V. Saillour, M. Ouimet, S. Langlois,
P. Cassart, J. Healy, E. Bareke, A. Droit, D. Sinnett.
3507
W Prediction of GWAS-identified risk loci in
breast cancer and correlated SNPs through mapped
epigenetic phenomena.
P. S. Rajagopal, Q. Li, P. Kraft,
M. Freedman.
3483
W Exome sequencing characterize the somatic
mutation spectrum of early serrated lesions in a
patient with
BRAF
negative hyperplastic polyposis
syndrome.
P. Hoffmann, S. Horpaopan, J. Altmueller,
R. Hueneburg, P. Kahl, D. Drichel, H. Thiele, I. Spier,
M. Odenthal, M. M. Noethen, C. Strassburg, H. Froehlich,
P. Nuernberg, R. Buettner, S. Aretz.
3484
T First identification of f equent somatic
VHL
gene
alterations in head and neck paragangliomas.
A. Merlo,
S. Bernaldo de Quirós, I. Saenz de Santamaría, C. Suarez,
M. D. Chiara.
3485
F Sensitive, highly multiplexed somatic mutation
analysis of FFPE tissues by deep amplicon sequencing
on MiSeq®.
C. Lin, K. Chang, E. Upsall, I. Lewis, A. Tian,
A. Iyer, G. Costa, R. Shen.
3486
W Alternatively spliced
DICER1
transcripts arising
from genomic point mutations.
M. Wu, L. de Kock,
L. Witkowski, M. R. Fabian, W. D. Foulkes.
3487
T A personalized mutation network approach
to detect putative cancer driver genes from next-
generation sequencing data.
Z. Zhao, P. Jia.
3488
F DNA copy number variation and expression
of miRNA150 suggestive as prognostic factor
for colorectal cancer.
R. V. Andrade, N. Gasparini,
L. Sakamoto, G. Pereira, T. Lins.
3489
W MicroRNA-192 regulates cellular proliferation in
medulloblastoma seeding by targeting of dihydrofolate
reductase.
S. A. Choi, S. Y. Yang, H. A. Kim, K. C. Wang,
J. H. Phi, J. Y. Lee, J. H. Choi, D. Y. Um, Y. J. Moon, P. A.
Kwak, E. J. Kwon, S. K. Kim.
3490
T Genome wide miRNA expression profile in oral
cancer: An exploratory study.
N. De Sarkar, B. Roy.
3491
F Germline
BAP1
mutations in sporadic and
familial mesothelioma.
I. Dianzani, M. Betti, E. Casalone,
D. Ferrante, A. Romanelli, F. Grosso, S. Guarrera, L. Righi,
G. Pelosi, R. Libener, D. Mirabelli, V. Ascoli, M. Papotti,
G. Matullo, C. Magnani.
3492
W The role of genetic ancestry in DNA repair
capacity among Puerto Rican women with breast
cancer.
H. J. Diaz-Zabala, L. Morales, J. Matta, J. Dutil.
3493
T A non-Smad TGF-
b
signaling pathway govern
adult stem cell state and breast cancer metastasis
with the cooperation of SLUG and SOX9.
H. Fazilaty,
B. Behnam.
3494
F Copy number variation and the expression
of miRNAs in colorectal cancer.
N. Gasparini, T. Lins,
S. Andreoli, L. Lemos, J. Lima, G. Pereira, L. Sakamoto,
R. Pereira, R. Pogue, R. Andrade.
3495
W Expression profiling of cofilin-1 in east
cancer cell lines and biopsies.
A. Hadjisavvas, C. Sutton,
S. Shaheed, P. Loadman, V. Speirs, A. Hanby, K. Kyriacou.